Multiple Sclerosis

Multiple Sclerosis is a demyelinating autoimmune disease of the CNS, resulting in symptoms including optic neuritis and motor weakness. Discover the latest research on Multiple Sclerosis here.

September 17, 2020

The "Journal of Functional Morphology and Kinesiology" Journal Club Series: PhysioMechanics of Human Locomotion

Journal of Functional Morphology and Kinesiology
Grazia MaugeriGiuseppe Musumeci
September 16, 2020

Does obesity exacerbate brain lesion volume and atrophy in patients with multiple sclerosis?

Multiple Sclerosis and Related Disorders
Rachel GaliotoStephen M Rao
September 17, 2020

7 T imaging reveals a gradient in spinal cord lesion distribution in multiple sclerosis

Brain : a Journal of Neurology
Russell OuelletteCaterina Mainero
September 17, 2020

Rehabilitation should be prescribed acutely in motor relapses - Commentary

Multiple Sclerosis : Clinical and Laboratory Research
Lara A Pilutti, Afolasade Fakolade
September 15, 2020
Open Access

Torsadogenic potential of a novel remyelinating drug clemastine for multiple sclerosis assessed in the rabbit proarrhythmia model

Journal of Pharmacological Sciences
Satoshi KawakamiAkira Takahara
September 16, 2020

Comparing patient OOP spending for specialty drugs in Medicare Part D and employer-sponsored insurance

The American Journal of Managed Care
Sonal ParasrampuriaGerard F Anderson
September 18, 2020

Physical activity, sitting time and exercise types, and associations with symptoms in Australian people with multiple sclerosis

Disability and Rehabilitation
Claudia H MarckIngrid van der Mei
September 16, 2020

Dimethyl fumarate-induced lymphocyte count drop is related to clinical effectiveness in relapsing-remitting multiple sclerosis

European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies
Elena TsantesFranco Granella
September 16, 2020

Powered exoskeletons for walking in multiple sclerosis

Multiple Sclerosis : Clinical and Laboratory Research
Peter Feys, Eva Swinnen
September 16, 2020

Enhancing quality of life in progressive multiple sclerosis with powered robotic exoskeleton

Multiple Sclerosis : Clinical and Laboratory Research
Seng Kwee WeeCheng Hong Ong
September 18, 2020
Open Access

Focal alteration of the intraretinal layers in neurodegenerative disorders

Annals of Eye Science
Shriya AirenHong Jiang
September 18, 2020
Preprint

Drug library screen identifies inhibitors of toxic astrogliosis

MedRxiv : the Preprint Server for Health Sciences
R. R. MasvekarBibiana Bielekova
September 18, 2020

The risk of infection in patients with multiple sclerosis treated with disease-modifying therapies: A Delphi consensus statement

Multiple Sclerosis : Clinical and Laboratory Research
Lucia MoiolaAgostino Riva
September 4, 2020
Review

Beyond Alzheimer's disease: Can bilingualism be a more generalized protective factor in neurodegeneration?

Neuropsychologia
Toms VoitsJason Rothman
September 17, 2020
Open Access

Multiple sclerosis

Clinical Medicine : Journal of the Royal College of Physicians of London
Shahid A Kausar
September 18, 2020

Pediatric multiple sclerosis - current status of epidemiology, diagnosis and treatment

Neurologia i neurochirurgia polska
Waldemar Brola, Barbara Steinborn
September 18, 2020

Inflammatory colitis associated with Teriflunomide

Multiple Sclerosis and Related Disorders
Neda Zarghami EsfahaniAnnette Wundes
September 18, 2020

Experimental autoimmune encephalomyelitis is associated with changes of the microbiota composition in the gastrointestinal tract

Scientific Reports
David M JohansonAlban Gaultier

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Acute Disseminated Encephalomyelitis

Acute disseminated encephalomyelitis (ADEM) is a rare inflammatory demyelinating disease of the central nervous system. Discover the latest research on acute disseminated encephalomyelitis here.

© 2020 Meta ULC. All rights reserved
/feed-previews/multiple-sclerosis/ea8d70cb-fbc6-4170-baee-bf863c65dc90